SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹10.00 Cr | ₹8.66 Cr | ₹7.76 Cr | ₹7.73 Cr | ₹6.27 Cr |
What is the latest Total Non-Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹10.00 Cr |
Mar2023 | ₹8.66 Cr |
Mar2022 | ₹7.76 Cr |
Mar2017 | ₹7.73 Cr |
Mar2016 | ₹6.27 Cr |
How is Total Non-Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹10.00 Cr | 15.49 | |
Mar2023 | ₹8.66 Cr | 11.53 | |
Mar2022 | ₹7.76 Cr | 0.36 | |
Mar2017 | ₹7.73 Cr | 23.39 | |
Mar2016 | ₹6.27 Cr | - |
Compare Total Non-Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,948.6 Cr | 5.4% | -5.9% | 29.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,661.0 Cr | -1.8% | 2.7% | 49.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,496.0 Cr | -0.2% | -3.4% | 57% | Stock Analytics | |
CIPLA | ₹121,970.0 Cr | -0.7% | 0.6% | 22.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,877.0 Cr | -1.8% | 11.3% | 18% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,163.2 Cr | 1.9% | 0.5% | 41.9% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | 5.4% |
-5.9% |
29.5% |
SENSEX | 0.7% |
-2% |
9.7% |
You may also like the below Video Courses